Literature DB >> 6088711

Phase II study of cisplatin in recurrent astrocytomas in adults: a Southwest Oncology Group Study.

D J Stewart, R M O'Bryan, M Al-Sarraf, J J Costanzi, N Oishi.   

Abstract

Thirty-one evaluable adults with recurrent astrocytomas were treated with Cisplatin 35 mg/m2 I.V. daily for three days every 3-4 weeks. All patients had previously been irradiated and most had previously received chemotherapy. Approximately half had poor performance status. Two patients experienced complete remissions and two additional patients experienced partial remissions. Three patients stabilized. Gastrointestinal toxicity was generally mild. Further studies are planned of Cisplatin in combination with other agents.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6088711     DOI： 10.1007/bf00182960

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  7 in total

1.  Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors.

Authors:  D J Stewart; M Leavens; M Maor; L Feun; M Luna; J Bonura; R Caprioli; T L Loo; R S Benjamin
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

2.  Action of Cis-dichlorodiammineplatinum(II) (NSC-119875) at ehe cellular level.

Authors:  B Drewinko; J A Gottlieb
Journal:  Cancer Chemother Rep       Date:  1975 May-Jun

Review 3.  Cis-diamminedichloroplatinum (II). A new anticancer drug.

Authors:  M Rozencweig; D D von Hoff; M Slavik; F M Muggia
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

4.  A phase I study of intracarotid artery infusion of cis-Diamminedichloroplatinum(II) in patients with recurrent malignant intracerebral tumors.

Authors:  D J Stewart; S Wallace; L Feun; M Leavens; S E Young; S Handel; G Mavligit; R S Benjamin
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

5.  Weekly Cisplatin during cranial irradiation for malignant melanoma metastatic to brain.

Authors:  D J Stewart; L G Feun; M Maor; M Leavens; M A Burgess; R S Benjamin; G P Bodey
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

6.  Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II).

Authors:  D J Stewart; R S Benjamin; S Zimmerman; R M Caprioli; S Wallace; V Chuang; D Calvo; M Samuels; J Bonura; T L Loo
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

7.  Human tissue distribution of platinum after cis-diamminedichloroplatinum.

Authors:  D J Stewart; R S Benjamin; M Luna; L Feun; R Caprioli; W Seifert; T L Loo
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333
  7 in total
  25 in total

Review 1.  Paediatric and adult malignant glioma: close relatives or distant cousins?

Authors:  Chris Jones; Lara Perryman; Darren Hargrave
Journal:  Nat Rev Clin Oncol       Date:  2012-05-29       Impact factor: 66.675

Review 2.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

3.  Local chemotherapy with cisplatin-depot for glioblastoma multiforme.

Authors:  Sergey V Sheleg; Eugeny A Korotkevich; Edvard A Zhavrid; Galina V Muravskaya; Arnold F Smeyanovich; Yury G Shanko; Tatsiana L Yurkshtovich; Pavel B Bychkovsky; Sergey A Belyaev
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

4.  Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients.

Authors:  Nicole E Marshall; Karla V Ballman; John C Michalak; Paula J Schomberg; Gary V Burton; Howard M Sandler; Terrence L Cascino; Kurt A Jaeckle; Jan C Buckner
Journal:  J Neurooncol       Date:  2006-05       Impact factor: 4.130

Review 5.  New agents in the treatment of primary brain tumors.

Authors:  S A Taylor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 6.  A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.

Authors:  D J Stewart
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 7.  The basis for current treatment recommendations for malignant gliomas.

Authors:  H A Fine
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Cisplatin plus cytosine arabinoside in adults with malignant gliomas.

Authors:  D J Stewart; M T Richard; B Benoit; H Hugenholtz; N Russell; J Dennery; E Peterson; Z Grahovac; G Belanger; S Aitkens
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

9.  Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.

Authors:  P Paoletti; G Butti; R Knerich; P Gaetani; R Assietti
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

10.  Combination chemotherapy with cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) in children with brain tumors.

Authors:  L J Ettinger; D Sinniah; S E Siegel; L S Fishman; H D Segall; D Soni; G A Bennetts; D H Schultz; D Raphael
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.